Excellent
Fully Aligned
Patient Risk:
Low
Summary
The claim is directly supported by the FDA label sections for both Edarbi and Edarbyclor, including fetal harm and the instruction to discontinue as soon as possible when pregnancy is detected.
Category Scores
Accurate Statements
“WARNING: FETAL TOXICITY” (fetal harm / injury and discontinuation upon pregnancy detection)
Edarbi: 5.1 Fetal Toxicity; 8.1 Pregnancy. Edarbyclor: 5.1 Fetal Toxicity; 8.1 Pregnancy. Each states fetal harm risk and: “When pregnancy is detected, discontinue … as soon as possible.”
Unsupported Statements
Contradictions
Important Omissions
Safety Assessment
Potential Patient Risk:
Low
The evaluated content accurately reflects the label’s pregnancy-related fetal toxicity warning and discontinuation instruction.
Regulatory Assessment
| On Label |
Yes |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
Low |
Recommendation
Fully Aligned
Primary Issue
Suggested Improvement